AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor ( uPAR ). AE105 binds tightly to the uPA-binding cavity of uPAR. AE105 can be used for the study of cancer [1].
References:
[1]. Leth JM, et al. Targeted imaging of uPAR expression in vivo with cyclic AE105 variants. Sci Rep. 2023 Oct 11;13(1):17248.
References:
[1]. Leth JM, et al. Targeted imaging of uPAR expression in vivo with cyclic AE105 variants. Sci Rep. 2023 Oct 11;13(1):17248.
















